Best Agrolife Q2 FY27 profit rises 48% despite sales fall

Best Agrolife Limited reported profit after tax of Rs 57 crore in the second quarter (Q2) of fiscal year (FY) 2027, 48% above Rs 39 crore a year earlier, although revenue fell 21% to Rs 407 crore. Its presentation linked the outcome to 60% patented-product contribution to branded sales, a 45% gross margin and a 12% operating-expenditure reduction.

Why did Best Agrolife's Q2 FY27 profit rise despite lower revenue?

Best Agrolife's Q2 FY27 profit rose because higher gross margin and lower operating expenditure outweighed lower sales. Revenue from operations fell to Rs 407 crore from Rs 517 crore in Q2 FY26, which Best Agrolife attributed to erratic rainfall, delayed sowing and lower crop-protection demand, while profit after tax rose to Rs 57 crore from Rs 39 crore.

Gross margin increased to Rs 182 crore in Q2 FY27 from Rs 170 crore in Q2 FY26 even as revenue declined by Rs 110 crore. Gross margin as a share of revenue rose to 45% from 33%, and Best Agrolife reported an expansion of 1,185 basis points, supported by its patented-product portfolio.

Earnings before interest, tax, depreciation and amortisation (EBITDA), calculated excluding other income, rose 30% to Rs 101 crore from Rs 78 crore. EBITDA margin increased to 25% from 15%, while Best Agrolife said regional restructuring reduced operating expenditure (OPEX) by 12% compared with Q2 FY26.

How did Best Agrolife's Q2 FY27 sales mix change?

Best Agrolife shifted its sales mix toward branded products in Q2 FY27, with branded sales rising to 81% from 69% in Q2 FY26. Institutional sales consequently declined to 19% from 31%, a 12-percentage-point change during a quarter in which total revenue fell 21% to Rs 407 crore.

Patented products accounted for 60% of branded sales in Q2 FY27, compared with 51% in Q2 FY26. Non-patented products accounted for the remaining 40%, down from 49%, and Best Agrolife described this movement as a shift toward proprietary formulations and higher-margin offerings.

Earnings per share (EPS) increased to Rs 1.62 in Q2 FY27 from Rs 1.10 in Q2 FY26, a reported 41% increase. Best Agrolife also reported sequential growth in revenue, gross margin, EBITDA and profit after tax compared with Q1 FY27, without providing Q1 FY27 values on these pages.

How did Best Agrolife perform in H1 FY27?

Best Agrolife reported the same revenue-and-margin pattern for the first half (H1) of FY27: revenue declined while profit and margins increased. H1 FY27 revenue from operations was Rs 803 crore, down 11% from Rs 898 crore in H1 FY26, with erratic rainfall, delayed sowing and lower crop-protection demand again cited for the decline.

Profit after tax increased 67% to Rs 98 crore in H1 FY27 from Rs 59 crore, while EBITDA increased 45% to Rs 178 crore from Rs 123 crore. Gross margin rose 17% to Rs 328 crore from Rs 280 crore, lifting the gross-margin percentage to 41% from 31%.

EBITDA margin reached 22% in H1 FY27, compared with 14% in H1 FY26, and Best Agrolife reported an 846-basis-point expansion. Profit-after-tax margin rose to 12% from 7%, while OPEX was 5% lower than in H1 FY26 following regional operational restructuring.

The H1 product mix also moved toward patented products. Branded sales represented 71% of sales versus 67% a year earlier, while patented products contributed 63% of branded sales compared with 49% in H1 FY26; EPS rose to Rs 2.77 from Rs 1.66.

What did Best Agrolife report on balance sheet and working capital?

Best Agrolife reported total assets of Rs 1,957 crore as of September 30, 2026, compared with Rs 1,963 crore on September 30, 2025 and Rs 1,686 crore on March 31, 2026. Current assets were Rs 1,591 crore, including inventories of Rs 786 crore, trade receivables of Rs 613 crore and cash and bank balances of Rs 83 crore.

Trade receivables were Rs 613 crore on September 30, 2026, down from Rs 783 crore a year earlier but above Rs 490 crore on March 31, 2026. Inventories were Rs 786 crore, compared with Rs 666 crore on September 30, 2025 and Rs 651 crore at March 31, 2026.

Working-capital days decreased to 207 in H1 FY27 from 247 in FY26, according to Best Agrolife's presentation. Receivable days fell to 124 from 151, inventory days declined to 272 from 292 and cash-conversion days reduced to 255 from 267.

The current ratio rose to 1.62 in H1 FY27 from 1.53 in FY26. Debt to equity was 0.53 versus 0.56, while net debt to equity was 0.43 versus 0.44; short-term borrowings at September 30, 2026 were Rs 382 crore and long-term borrowings were Rs 73 crore.

What product launches and registrations did Best Agrolife report?

Best Agrolife reported a patent grant for the Fluxametamide, Abamectin and Trifloxystrobin combination, and said it secured 13 new Central Insecticides Board registrations during the quarter. Listed registrations included Fluxametamide 5% plus Flonicamid 15% plus Abamectin 1.5% ME, Fluxapyroxad 333 grams per litre FS, Fluxametamide 10% EC and Cyclanilprole Technical 95%.

The company listed patented launches including Fluzam for groundnut, Cubax Power Extra for chilli and Midcotin for paddy. It also reported a 47-metric-ton shipment to Sudan, one patented-product registration in Nepal with four more submitted, one technical-product registration in Mexico, a Taiwan product at final approval stage, and Sri Lankan testing planned for two patented products after initial approval.

Conclusion

Best Agrolife's Q2 FY27 results show that a lower-revenue period still produced higher profit as its branded and patented product mix changed and OPEX declined. Revenue fell 21% year on year, yet gross margin rose to 45%, EBITDA reached Rs 101 crore and profit after tax increased 48% to Rs 57 crore.

The next reported periods will show whether the 60% patented contribution to branded Q2 sales and the 12% OPEX reduction persist as crop-protection demand develops. Management's disclosed pipeline includes four Nepal products submitted for registration, a Mexican technical product in progress, a Taiwan product at final approval stage and trials for two patented products in Sri Lanka.